Browse drugs

…nsporter 2 inhibitors, and insulin, as well as length of use of metformin, sulfonylureas, thiazolidinediones, dipeptidyl peptidase 4 inhi…

… among the GLP-1RA group compared with the sulfonylureas group. GLP-1RA=glucagon-like peptide-1 receptor agonistsDiscussionIn this nati…

…s Affairs users with type 2 diabetes who started treatment with GLP-1RAs (n=132 551) or sulfonylureas (n=201 136), followed up for three…

…erans Affairs healthcare system with type 2 diabetes initiating GLP-1RA (n=132 551) or sulfonylureas (n=201 136) between 1 January 2017…

…es: 552 065 initiated SGLT-2 inhibitors and 1 480 092 initiated sulfonylureas.Main outcome measures The primary outcome was autoimmune rheuma…

…ined as diet alone or oral agents with no risk of hypoglycemia (metformin, dipeptidyl peptidase-4 inhibitors and sodium–glucose cotranspo…

…2.67, 71 subjects were on oral hypoglycemic medications such as metformin, sulfonylureas, pioglitazone, DPP-4 inhibitors, and SGLT2 inhib…

…ssociation. One potential explanation is the high prevalence of statin use among patients, which may have attenuated the variability i…

…th diabetes (n=23), 14 (60.9%) are on insulin, 9 (39.1%) are on metformin, 7 (30.4%) are on SGLT2 inhibitors,5 (14.7%) are on sulfonylure…

…d significantly after intervention (−2.0% per quarter; p=0.02). Insulin prescribing rates did not change throughout the study period. T…